Publications of Niramol Savaraj - University of Miami

172 Publications

This view shows all the publications associated to this researcher. Select a tab to view the documents within each secion. If you are an authorized user, you can add content by selecting the Edit your profile button above. Access to this tool is managed by a project team at your institution.

Jump to:

Books
Book Chapters
Conference Proceedings
Meeting Abstracts
Presentations
Technical Reports
Other Written Works

172 Publications from Scopus

This is a list of publications by this researcher, listed chronologically starting with the most recent first. New publications appear in this list weekly. The source of publications and 'cited by' data for this application is Scopus.

sort by year | cited by

Select All | Save icon

Export

1.
2013

Min You; Niramol Savaraj; MacUs T. Kuo; Medhi Wangpaichitr; Javier Varona-Santos; Chunjing Wu; Dao M. Nguyen; Lynn Feun

TRAIL induces autophagic protein cleavage through caspase activation in melanoma cell lines under arginine deprivation
Molecular and Cellular Biochemistry. 2013;374(1-2):181-190.

0
2.
2012

Medhi Wangpaichitr; Elizabeth J. Sullivan; George Theodoropoulos; Chunjing Wu; Min You; Lynn G. Feun; Theodore J. Lampidis; Macus T. Kuo; Niramol Savaraj

The relationship of thioredoxin-1 and cisplatin resistance: Its impact on ROS and oxidative metabolism in lung cancer cells
Molecular Cancer Therapeutics. 2012;11(3):604-615.

0
3.
2012

L.G. Feun; A. Marini; G. Walker; G. Elgart; F. Moffat; S.E. Rodgers; C.J. Wu; M. You; M. Wangpaichitr; M.T. Kuo; et al.

Negative argininosuccinate synthetase expression in melanoma tumours may predict clinical benefit from arginine-depleting therapy with pegylated arginine deiminase
British Journal of Cancer. 2012;106(9):1481-1485.

1
4.
2012

Wen-Bin Tsai; Isamu Aiba; Yan Long; Hui-Kuan Lin; Lynn Feun; Niramol Savaraj; Macus Tien Kuo

Activation of Ras/PI3K/ERK pathway induces c-Myc stabilization to upregulate argininosuccinate synthetase, leading to arginine deiminase resistance in melanoma cells
Cancer Research. 2012;72(10):2622-2633.

3
5.
2012

Zheng D. Liang; Wen-Bin Tsai; Mei-Yi Lee; Niramol Savaraj; Macus Tien Kuo

Specificity protein 1 (Sp1) oscillation is involved in copper homeostasis maintenance by regulating human high-affinity copper transporter 1 expression
Molecular Pharmacology. 2012;81(3):455-464.

6
6.
2012

Zheng D. Liang; Yan Long; Wen-Bin Tsai; Siqing Fu; Razelle Kurzrock; Mihai Gagea-Iurascu; Fan Zhang; Helen H. W. Chen; Bryan T. Hennessy; Gordon B. Mills; et al.

Mechanistic basis for overcoming platinum resistance using copper chelating agents
Molecular Cancer Therapeutics. 2012;11(11):2483-2494.

1
7.
2012

Macus Tien Kuo; Siqing Fu; Niramol Savaraj; Helen H. W. Chen

Role of the human high-affinity copper transporter in copper homeostasis regulation and cisplatin sensitivity in cancer chemotherapy
Cancer Research. 2012;72(18):4616-4621.

0
8.
2011

Haibin Xi; Metin Kurtoglu; Huaping Liu; Medhi Wangpaichitr; Min You; Xiongfei Liu; Niramol Savaraj; Theodore J. Lampidis

2-Deoxy-d-glucose activates autophagy via endoplasmic reticulum stress rather than ATP depletion
Cancer Chemotherapy and Pharmacology. 2011;67(4):899-910.

14
9.
2010

Macus Tien Kuo; Niramol Savaraj; Lynn G Feun

Targeted cellular metabolism for cancer chemotherapy with recombinant arginine-degrading enzymes.
Oncotarget. 2010;1(4):246-251.

14
10.
2010

Min You; Niramol Savaraj; Medhi Wangpaichitr; Chunjing Wu; M. Tien Kuo; Javier Varona-Santos; Dao M. Nguyen; Lynn Feun

The combination of ADI-PEG20 and TRAIL effectively increases cell death in melanoma cell lines
Biochemical and Biophysical Research Communications. 2010;394(3):760-766.

7
11.
2010

N. Savaraj; M. You; C. Wu; M. Wangpaichitr; M.T. Kuo; L.G. Feun

Arginine deprivation, autophagy, apoptosis (aaa) for the treatment of melanoma
Current Molecular Medicine. 2010;10(4):405-412.

17
12.
2010

Joshua P. Sasine; Niramol Savaraj; Lynn G. Feun

Topoisomerase I inhibitors in the treatment of primary CNS malignancies: An update on recent trends
Anti-Cancer Agents in Medicinal Chemistry. 2010;10(9):683-696.

2
13.
2009

Zheng D. Liang; David Stockton; Niramol Savaraj; Macus Tien Kuo

Mechanistic comparison of human high-affinity copper transporter 1-mediated transport between copper ion and cisplatin
Molecular Pharmacology. 2009;76(4):843-853.

14
14.
2009

Wen-Bin Tsai; Isamu Aiba; Soo-Yong Lee; Lynn Feun; Niramol Savaraj; Macus Tien Kuo

Resistance to arginine deiminase treatment in melanoma cells is associated with induced argininosuccinate synthetase expression involving c-Myc/HIF-1α/Sp4
Molecular Cancer Therapeutics. 2009;8(12):3223-3233.

17
15.
2008

L. Feun; M. You; C.J. Wu; M.T. Kuo; M. Wangpaichitr; S. Spector; N. Savaraj

Arginine deprivation as a targeted therapy for cancer
Current Pharmaceutical Design. 2008;14(11):1049-1057.

44
16.
2008

Medhi Wangpaichitr; Chunjing Wu; Min You; M.T. Kuo; Lynn Feun; Theodore Lampidis; Niramol Savaraj

Inhibition of mTOR restores cisplatin sensitivity through down-regulation of growth and anti-apoptotic proteins
European Journal of Pharmacology. 2008;591(1-3):124-127.

31
17.
2008

Medhi Wangpaichitr; Niramol Savaraj; Johnathan Maher; Metin Kurtoglu; Theodore J. Lampidis

Intrinsically lower AKT, mammalian target of rapamycin, and hypoxia-inducible factor activity correlates with increased sensitivity to 2-deoxy-D-glucose under hypoxia in lung cancer cell lines
Molecular Cancer Therapeutics. 2008;7(6):1506-1513.

11
18.
2008

Helen H. W. Chen; Im-Sook Song; Anwar Hossain; Min-Koo Choi; Yoshiaki Yamane; Zheng D. Liang; Jia Lu; Lily Y.-H. Wu; Zahid H. Siddik; Leo W. J. Klomp; et al.

Elevated glutathione levels confer cellular sensitization to cisplatin toxicity by up-regulation of copper transporter hCtr1
Molecular Pharmacology. 2008;74(3):697-704.

23
19.
2008

Lynn Feun; Niramol Savaraj

Topoisomerase I inhibitors for the treatment of brain tumors
Expert Review of Anticancer Therapy. 2008;8(5):707-716.

13
20.
2007

Johnathan C. Maher; Medhi Wangpaichitr; Niramol Savaraj; Metin Kurtoglu; Theodore J. Lampidis

Hypoxia-inducible factor-1 confers resistance to the glycolytic inhibitor 2-deoxy-D-glucose
Molecular Cancer Therapeutics. 2007;6(2):732-741.

34
21.
2007

Lynn G. Feun; Angela Marini; Howard Landy; Arnold Markoe; Deborah Heros; Carlos Robles; Cristina Herrera; Niramol Savaraj

Clinical trial of CPT-11 and VM-26/VP-16 for patients with recurrent malignant brain tumors
Journal of Neuro-Oncology. 2007;82(2):177-181.

13
22.
2007

Macus Tien Kuo; Helen H. W. Chen; Im-Sook Song; Niramol Savaraj; Toshihisa Ishikawa

The roles of copper transporters in cisplatin resistance
Cancer and Metastasis Reviews. 2007;26(1):71-83.

88
23.
2007

Vy Dinh; Lynn Feun; George Elgart; Niramol Savaraj

Merkel Cell Carcinomas
Hematology/Oncology Clinics of North America. 2007;21(3):527-544.

15
24.
2007

Metin Kurtoglu; Ningguo Gao; Jie Shang; Johnathan C. Maher; Mark A. Lehrman; Medhi Wangpaichitr; Niramol Savaraj; Andrew N. Lane; Theodore J. Lampidis

Under normoxia, 2-deoxy-D-glucose elicits cell death in select tumor types not by inhibition of glycolysis but by interfering with N-linked glycosylation
Molecular Cancer Therapeutics. 2007;6(11):3049-3058.

43
25.
2006

M. Tien Kuo; Yingjie Wei; Xinlin Yang; Shigeru Tatebe; Jinsong Liu; Patricia Troncoso; Aysegul Sahin; Jae Y. Ro; Stanly R. Hamilton; Niramol Savaraj

Association of fragile site-associated (FSA) gene expression with epithelial differentiation and tumor development
Biochemical and Biophysical Research Communications. 2006;340(3):887-893.

2
26.
2006

Yingjie Wei; Yen-Chiu Lin-Lee; Xinlin Yang; Wenping Dai; Sheng Zhao; Feyruz V. Rassool; George W. Elgart; Lynn Feun; Niramol Savaraj; M. Tien Kuo

Molecular cloning of Chinese hamster 1q31 chromosomal fragile site DNA that is important to mdr1 gene amplification reveals a novel gene whose expression is associated with spermatocyte and adipocyte differentiation
Gene. 2006;372(1-2):44-52.

1
27.
2006

Lynn Feun; Niramol Savaraj

Pegylated arginine deiminase: A novel anticancer enzyme agent
Expert Opinion on Investigational Drugs. 2006;15(7):815-822.

23
28.
2006

M. Tien Kuo; Niramol Savaraj

Roles of reactive oxygen species in hepatocarcinogenesis and drug resistance gene expression in liver cancers
Molecular Carcinogenesis. 2006;45(9):701-709.

28
29.
2005

Paolo A. Ascierto; Stefania Scala; Giuseppe Castello; Antonio Daponte; Ester Simeone; Alessandro Ottaiano; Gerardo Beneduce; Vincenzo De Rosa; Francesco Izzo; Maria Teresa Melucci; et al.

Pegylated arginine deiminase treatment of patients with metastatic melanoma: Results from phase I and II studies
Journal of Clinical Oncology. 2005;23(30):7660-7668.

80
30.
2005

Niramol Savaraj; Chunjing Wu; Howard Landy; Medhi Wangpaijit; Yingjie Wei; M. Tien Kuo; Carlos Robles; A.J. Furst; Theodore Lampidis; Lynn Feun

Procollagen alpha 1 type I: A potential aide in histopathological grading of glioma
Cancer Investigation. 2005;23(7):577-581.

4
31.
2005

N. Savaraj; C.J. Wu

Erratum: Article on human copper transporter Ctr1 and cisplatin (Molecular Cancer Therapeutics (2004))
Molecular Cancer Therapeutics. 2005;4(5):864.

0
32.
2005

Niramol Savaraj; Yingjie Wei; Hitoshi Unate; Pei-Man Liu; C.J. Wu; Medhi Wangpaichitr; Diran Xia; Hong-Ji Xu; Shi-Xu Hu; M. Tien Kuo

Redox regulation of matrix metalloproteinase gene family in small cell lung cancer cells
Free Radical Research. 2005;39(4):373-381.

17
33.
2005

Chunjing Wu; Medhi Wangpaichitr; Lynn Feun; Marcus Tien Kuo; Carlos Robles; Theodore Lampidis; Niramol Savaraj

Overcoming cisplatin resistance by mTOR inhibitor in lung cancer
Molecular Cancer. 2005;4.

63
34.
2005

Johnathan C Maher; Niramol Savaraj; Waldemar Priebe; Huaping Liu; Theodore J Lampidis

Differential sensitivity to 2-deoxy-D-glucose between two pancreatic cell lines correlates with GLUT-1 expression.
Pancreas. 2005;30(2):e34-39.

20
35.
2005

Lynn Feun; Angela Marini; Frederick Moffat; Niramol Savaraj; Judith Hurley; Amitabha Mazumder

Cyclosporine A, alpha-interferon and interleukin-2 following chemotherapy with BCNU, DTIC, cisplatin, and tamoxifen: A phase II study in advanced melanoma
Cancer Investigation. 2005;23(1):3-8.

5
36.
2004

Gregory Maschek; Niramol Savaraj; Waldemar Priebe; Paul Braunschweiger; Kara Hamilton; George F. Tidmarsh; Linda R. De Young; Theodore J. Lampidis

2-Deoxy-D-glucose Increases the Efficacy of Adriamycin and Paclitaxel in Human Osteosarcoma and Non-Small Cell Lung Cancers in Vivo
Cancer Research. 2004;64(1):31-34.

155
37.
2004

Howard Landy; Arnold Markoe; Priscilla Potter; Garrett Lasalle; Angela Marini; Niramol Savaraj; Isildinha Reis; Deborah Heros; Medhi Wangpaichitr; et al.

Pilot study of estramustine added to radiosurgery and radiotherapy for treatment of high grade glioma
Journal of Neuro-Oncology. 2004;67(1-2):215-220.

9
38.
2004

Im-Sook Song; Niramol Savaraj; Zahid H. Siddik; Peiman Liu; Yingjie Wei; Chun Jing Wu; Macus Tien Kuo

Role of human copper transporter Ctr1 in the transport of platinum-based antitumor agents in cisplatin-sensitive and cisplatin-resistant cells
Molecular Cancer Therapeutics. 2004;3(12):1543-1549.

75
39.
2003

Lynn G. Feun; Christopher O'Brien; Enrique Molina; Miguel Rodriguez; Lenox Jeffers; Eugene R. Schiff; Angela Marini; Niramol Savaraj; Bach Ardalan

Recombinant leukocyte interferon, doxorubicin, and 5FUDR in patients with hepatocellular carcinoma-A phase II trial
Journal of Cancer Research and Clinical Oncology. 2003;129(1):17-20.

6
40.
2003

Ling He; He-Xi Chang; Ting-Chao Chou; Niramol Savaraj; C.C. Cheng

Design of antineoplastic agents based on the '2-phenylnaphthalene-type' structural pattern - Synthesis and biological activity studies of 11H-indolo[3.2-c]quinoline derivatives
European Journal of Medicinal Chemistry. 2003;38(1):101-107.

33
41.
2003

Yan-Ping Hu; Bushra Haq; Kermit L. Carraway; Niramol Savaraj; Theodore J. Lampidis

Multidrug resistance correlates with overexpression of Muc4 but inversely with P-glycoprotein and multidrug resistance related protein in transfected human melanoma cells
Biochemical Pharmacology. 2003;65(9):1419-1425.

17
42.
2003

John Murren; Manuel Modiano; Caroline Clairmont; Paula Lambert; Niramol Savaraj; Terry Doyle; Mario Sznol

Phase I and pharmacokinetic study of Triapine, a potent ribonucleotide reductase inhibitor, administered daily for five days in patients with advanced solid tumors
Clinical Cancer Research. 2003;9(11):4092-4100.

53
43.
2003

Niramol Savaraj; Chunjing Wu; Medhi Wangpaichitr; Macus Tien Kuo; Theodore Lampidis; Carlos Robles; A.J. Furst; Lynn Feun

Overexpression of mutated MRP4 in cisplatin resistant small cell lung cancer cell line: collateral sensitivity to azidothymidine.
International journal of oncology. 2003;23(1):173-179.

16
44.
2003

C. Robles; A.J. Furst; P. Sriratana; S. Lai; L. Chua; E. Donnelly; J. Solomon; M. Sundaram; L. Feun; N. Savaraj

Phase II study of vinorelbine with low dose prednisone in the treatment of hormone-refractory metastatic prostate cancer.
Oncology reports. 2003;10(4):885-889.

5
45.
2002

Lynn Feun; Manuel Modiano; King Lee; John Mao; Angela Marini; Niramol Savaraj; Patricia Plezia; Bijan Almassian; Elizabeth Colacino; et al.

Phase I and pharmacokinetic study of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) using a single intravenous dose schedule
Cancer Chemotherapy and Pharmacology. 2002;50(3):223-229.

57
46.
2002

Shigeru Tatebe; Hitoshi Unate; Frank A. Sinicrope; Takashi Sakatani; Kenji Sugamura; Masato Makino; Hisao Ito; Niramol Savaraj; Nobuaki Kaibara; M. Tien Kuo

Induction of immune tolerance toward tumor-associated-antigens enables growth of human hepatoma in mice
International Journal of Cancer. 2002;97(1):52-57.

15
47.
2002

Lynn G. Feun; Niramol Savaraj; Judith Hurley; Angela Marini

Phase II trial of Paclitaxel and Dacarbazine with filgrastim administration in advanced malignant melanoma
Cancer Investigation. 2002;20(3):357-361.

6
48.
2002

Huaping Liu; Niramol Savaraj; Waldemar Priebe; Theodore J Lampidis

Hypoxia increases tumor cell sensitivity to glycolytic inhibitors: A strategy for solid tumor therapy (Model C)
Biochemical Pharmacology. 2002;64(12):1745-1751.

43
49.
2001

Yen-Chiu Lin-Lee; Shigeru Tatebe; Niramol Savaraj; Toshihisa Ishikawa; M. Tien Kuo

Differential sensitivities of the MRP gene family and γ-glutamylcysteine synthetase to prooxidants in human colorectal carcinoma cell lines with different p53 status
Biochemical Pharmacology. 2001;61(5):555-563.

38
50.
2001

H. Liu; Y.P. Hu; N. Savaraj; W. Priebe; T.J. Lampidis

Hypersensitization of tumor cells to glycolytic inhibitors
Biochemistry. 2001;40(18):5542-5547.

77
51.
2000

Lynn G. Feun; Niramol Savaraj; Judith Hurley; Angela Marini; Shenghan Lai

A clinical trial of intravenous vinorelbine tartrate plus tamoxifen in the treatment of patients with advanced malignant melanoma
Cancer. 2000;88(3):584-588.

21
52.
2000

Jiangying Zou; Howard Landy; Lynn Feun; Rong Xu; Theodore Lampidis; Chun Jing Wu; A.J. Furst; Niramol Savaraj

Correlation of a unique 220-kDa protein with vitamin D sensitivity in glioma cells
Biochemical Pharmacology. 2000;60(9):1361-1365.

7
53.
2000

Yan-Ping Hu; Carlos T. Moraes; Niramol Savaraj; Waldemar Priebe; Theodore J. Lampidis

ρ⁰ Tumor cells: A model for studying whether mitochondria are targets for rhodamine 123, doxorubicin, and other drugs
Biochemical Pharmacology. 2000;60(12):1897-1905.

23
54.
1999

Despina Kolonias; Tchao Podona; Niramol Savaraj; Laurent Gate; Paul Cossum; Theodore J. Lampidis

Comparison of annamycin to adriamycin in cardiac and MDR tumor cell systems
Anticancer Research. 1999;19(2 A):1277-1283.

3
55.
1999

Koichi Yamazaki; Gina Spruill; Joseph Rhoderick; Julie Spielman; Niramol Savaraj; Eckhard R. Podack

Small cell lung carcinomas express shared and private tumor antigens presented by HLA-A1 or HLA-A2
Cancer Research. 1999;59(18):4642-4650.

16
56.
1999

He-Xi Chang; Ting-Chao Chou; Niramol Savaraj; Leroy F. Liu; Chiang Yu; C.C. Cheng

Design of antineoplastic agents based on the '2-phenylnaphthalene-type' structural pattern. 4. Synthesis and biological activity of 2-chloro-3- (substituted phenoxy)-1,4-naphthoquinones and related 5,8-dihydroxy-1,4- naphthoquinones
Journal of Medicinal Chemistry. 1999;42(3):405-408.

29
57.
1999

Lynn G. Feun; K. Rajender Reddy; Thomas Scagnelli; Jose M. Yrizarry; Jorge J. Guerra; Edward Russell; Marcy Schwartz; Niramol Savaraj; Alan S. Livingstone; Joe U. Levi; et al.

A phase I study of chemoembolization with cisplatin, thiotepa, and lipiodol for primary and metastatic liver cancer
American Journal of Clinical Oncology: Cancer Clinical Trials. 1999;22(4):375-380.

8
58.
1998

M. Tien Kuo; Jia-Ju Bao; Masato Furuichi; Yoshiaki Yamane; Akira Gomi; Niramol Saharaj; Toshio Masuzawa; Toshihisa Ishikawa

Frequent coexpression of MRP/GS-X pump and γ-glutamylcysteine synthetase mRNA in drug-resistant cells, untreated tumor cells, and normal mouse tissues
Biochemical Pharmacology. 1998;55(5):605-615.

47
59.
1998

Waldemar Priebe; Marta Krawczyk; M. Tien Kuo; Yoshiaki Yamane; Niramol Savaraj; Toshihisa Ishikawa

Doxorubicin- and daunorubicin-glutathione conjugates, but not unconjugated drugs, competitively inhibit leukotriene C₄ transport mediated by MRP/GS-X pump
Biochemical and Biophysical Research Communications. 1998;247(3):859-863.

55
60.
1997

Khingkan Lertratanangkoon; Chun J. Wu; Niramol Savaraj; Mary L. Thomas

Alterations of DNA methylation by glutathione depletion
Cancer Letters. 1997;120(2):149-156.

28
61.
1997

T.J. Lampidis; Y.-F. Shi; C.L. Calderon; D. Kolonias; H. Tapiero; N. Savaraj

Accumulation of simple organic cations correlates with differential cytotoxicity in multidrug-resistant and -sensitive human and rodent cells
Leukemia. 1997;11(7):1156-1159.

17
62.
1997

Niramol Savaraj; Rong Xu; Howard Landy; Shenghan Lai; Linda Sternau; Jeannine Solomon; Chun Jing Wu; Theodore Lampidis; Lynn G. Feun

Comparison of topoisomerase I and II expression in primary brain tumor and lung cancer
Oncology Reports. 1997;4(4):857-861.

1
63.
1997

T.J. Lampidis; D. Kolonias; T. Podona; M. Israel; A.R. Safa; L. Lothstein; N. Savaraj; H. Tapiero; W. Priebe

Circumvention of P-GP MDR as a function of anthracycline lipophilicity and charge
Biochemistry. 1997;36(9):2679-2685.

60
64.
1997

Khingkan Lertratanangkoon; Niramol Savaraj; Joseph M. Scimeca; Mary L. Thomas

Glutathione depletion-induced thymidylate insufficiency for DNA repair synthesis
Biochemical and Biophysical Research Communications. 1997;234(2):470-475.

15
65.
1997

Niramol Savaraj; Chun Jing Wu; Rong Xu; Theodore Lampidis; Shenghan Lai; Elizabeth Donnelly; Jeanine Solomon; Lynn G. Feun

Multidrug-resistant gene expression in small-cell lung cancer
American Journal of Clinical Oncology: Cancer Clinical Trials. 1997;20(4):398-403.

27
66.
1996

Lynn G. Feun; Niramol Savaraj; Jeanine Solomon; Amy Liebmann; Judith Hurley

Phase II trial of mitoxantrone and cisplatin in advanced non-small-cell lung cancer
American Journal of Clinical Oncology: Cancer Clinical Trials. 1996;19(2):190-192.

1
67.
1996

Jia Xu; Tina Tyan; Edward Cedrone; Niramol Savaraj; Nancy Wang

Detection of 11q13 amplification as the origin of a homogeneously staining region in small cell lung cancer by chromosome microdissection
Genes Chromosomes and Cancer. 1996;17(3):172-178.

20
68.
1995

Danièle Brouty-Boyé; Despina Kolonias; Chun Jing Wu; Niramol Savaraj; Theodore J. Lampidis

Relationship of multidrug resistance to rhodamine-123 selectivity between carcinoma and normal epithelial cells: Taxol and vinblastine modulate drug efflux
Cancer Research. 1995;55(8):1633-1638.

19
69.
1995

L.G. Feun; N. Savaraj; F. Moffat; D. Robinson; A. Liebmann; J. Hurley; W.A. Raub Jr.; S.P. Richman

Phase II trial of recombinant interferon-α with BCNU, cisplatin, DTIC and tamoxifen in advanced malignant melanoma
Melanoma Research. 1995;5(4):273-276.

15
70.
1995

P.A. Cassileth; E. Podack; K. Sridhar; N. Savaraj; J. Hanlon

Phase I study of transfected cancer cells expressing the interleukin-2 gene product in limited stage small cell lung cancer
Human Gene Therapy. 1995;6(3):369-383.

25
71.
1995

L.G. Feun; W.A. Robinson; N. Savaraj; R. Gonzalez; A. Liebmann; K. Offenhauser; N.J. Clendeninn

Phase II trial of piritrexim and DTIC using an alternating dose schedule in metastatic melanoma
American Journal of Clinical Oncology: Cancer Clinical Trials. 1995;18(6):488-490.

9
72.
1994

L.G. Feun; N. Savaraj; P. Benedetto; S. Waldman; M. Collier; N.J. Clendennin

Oral piritrexim in advanced bladder cancer: An effective drug after progression on MVAC chemotherapy?
American Journal of Clinical Oncology: Cancer Clinical Trials. 1994;17(5):448-451.

10
73.
1994

L.G. Feun; W.A. Raub Jnr; R.C. Duncan; F. Moffat; N. Savaraj; A. Nemeth; A. Markoe; E. Trapido

Melanoma in a southeastern Hispanic population
Cancer Detection and Prevention. 1994;18(2):145-152.

14
74.
1994

L.G. Feun; N. Savaraj; S. Hung; R. Reddy; L. Jeffers; P. Benedetto; A.S. Livingstone; B. Ardalan; J.U. Levi; T. Parker; et al.

A Phase II trial of recombinant leukocyte interferon plus doxorubicin in patients with hepatocellular carcinoma
American Journal of Clinical Oncology: Cancer Clinical Trials. 1994;17(5):393-395.

14
75.
1994

L.G. Feun; N. Savaraj; H.J. Landy

Drug resistance in brain tumors
Journal of Neuro-Oncology. 1994;20(2):165-176.

38
76.
1994

L.G. Feun; K.R. Reddy; J.M. Yrizarry; N. Savaraj; J.J. Guerra Jr.; R.K. Purser; S. Waldman; J.U. Levi; F. Moffatt; L. Morrell; et al.

A Phase I study of chemoembolization with cisplatin and lipiodol for primary and metastatic liver cancer
American Journal of Clinical Oncology: Cancer Clinical Trials. 1994;17(5):405-410.

18
77.
1994

N. Savaraj; T.J. Lampidis; J.-Y. Zhao; C.J. Wu; L.D. Teeter; M.T. Kuo

Two multidrug-resistant friend leukemic cell lines selected with different drugs exhibit overproduction of different P-glycoproteins
Cancer Investigation. 1994;12(2):138-144.

5
78.
1994

J.-Y. Zhao; N. Savaraj; R. Song; W. Priebe; M. Tien Kuo

Overexpression of P-glycoprotein but not its mRNA in multidrug resistant cells selected with hydroxyrubicin
Anticancer Research. 1994;14(5 A):1735-1742.

6
79.
1993

T.C. Hsu; L. Feun; Z. Trizna; N. Savaraj; L.R. Shirley; C.L. Furlong; S.P. Schantz; R.S. Weber; T.-J. Shen; et al.

Differential sensitivity among three human subpopulations in response to 4-nitroquinoline-1-oxide and to bleomycin
International Journal of Oncology. 1993;3(5):827-830.

12
80.
1993

L.G. Feun; G. Blyden; J. Yrizarry; M. Dorvil; S. Waldman; P. Benedetto; E. Donnelly; J. Curtas; M. George; N. Savaraj

Clinical and pharmacological study of intrahepatic artery infusion of Thiotepa
Cancer Biotherapy. 1993;8(1):43-48.

6
81.
1993

N. Savaraj; L.G. Feun; G. Blyden; J.M. Yrizarry; J.-T.G. Hsiang; J. Curtas; S. Waldman; J.D. Post; P. Benedetto; H. Landy; et al.

A pilot clinical and pharmacological study of intra-arterial infusion of Thiotepa
Cancer Biotherapy. 1993;8(1):37-42.

0
82.
1993

K.S. Sridhar; R.J. Thurer; A.M. Markoe; H.T. Chatoor; G. Fountzilas; W.J. Raub; N. Savaraj; E.J. Beattie

Multidisciplinary approach to the treatment of locally and regionally advanced non-small cell lung cancer: University of Miami experience
Seminars in Surgical Oncology. 1993;9(2):114-119.

10
83.
1993

C.C. Cheng; Qing Dong; Dun-Fu Liu; Yi-Lin Luo; Leroy F. Liu; Allan Y. Chen; Chiang Yu; Niramol Savaraj; Ting-Chao Chou

Design of antineoplastic agents on the basis of the "2-phenylnaphthalene-type" structural pattern. 2. synthesis and biological activity studies of benzo[b]naphtho[2,3-d]furan-6,11-dione derivatives
Journal of Medicinal Chemistry®. 1993;36(25):4108-4112.

40
84.
1992

M. Dellinger; B.C. Pressman; C. Calderon-Higginson; N. Savaraj; H. Tapiero; D. Kolonias; T.J. Lampidis

Structural requirements of simple organic cations for recognition by multidrug-resistant cells
Cancer Research. 1992;52(22):6385-6389.

21
85.
1992

M.L.G. Moore; N. Savaraj; L.G. Feun; E. Donnelly

Successful therapy of peritoneal mesothelioma with intraperitoneal chemotherapy alone: A case report
American Journal of Clinical Oncology: Cancer Clinical Trials. 1992;15(6):528-530.

8
86.
1992

L.G. Feun; N. Savaraj; J. Bujnoski; S. Nadeem

Spinal cord compression produced by osteomyelitis mimicking spinal epidural metastasis
American Journal of Clinical Oncology: Cancer Clinical Trials. 1992;15(2):174-179.

3
87.
1992

D. Brouty-Boye; D. Kolonias; N. Savaraj; T.J. Lampidis

α-Smooth muscle actin expression in cultured cardiac fibroblasts of newborn rat
In Vitro Cellular and Developmental Biology - Animal. 1992;28 A(4):293-296.

4
88.
1992

Bach Ardalan; Kasi Stridhar; Rajender Reddy; Pasquale Benedetto; Stephen Richman; Stuart Waldman; Louise Morrell; Lynn Feun; Niramol Savaraj; Alan Livingstone

Phase I study of high dose 5-fluorouracil and high dose leucovorin with low dose phosphonacetyl-l-aspartic acid in patients with advanced malignancies
International Journal of Radiation Oncology, Biology, Physics. 1992;22(3):511-514.

1
89.
1992

T.J. Lampidis; D. Kolonias; N. Savaraj; R.W. Rubin

Cardiostimulatory and antiarrhythmic activity of tubulin-binding agents
Proceedings of the National Academy of Sciences of the United States of America. 1992;89(4):1256-1260.

34
90.
1992

K.S. Sridhar; A.M. Hussein; P. Benedetto; B. Ardalan; N. Savaraj; S.P. Richman

Phase II trial of 4'-O-tetrahydropyranyladriamycin (Pirarubicin) in head and neck carcinoma
Cancer. 1992;70(6):1591-1597.

8
91.
1992

N. Savaraj; L.G. Feun; K. Lu; K. Gray; C. Wang; Ti Li Loo

Pharmacology of intrathecal VP-16-213 in dogs
Journal of Neuro-Oncology. 1992;13(3):211-215.

6
92.
1992

W.A. Raub Jr.; L.G. Feun; R.C. Duncan; F. Moffat; N. Savaraj; A. Nemeth; A. Markoe

Descriptive analysis of the tumor registry experience for malignant melanoma from 1977 to 1986 at the University of Miami School of Medicine/Jackson Memorial Hospital.
Cancer Detection and Prevention. 1992;16(3):193-201.

0
93.
1991

K.S. Sridhar; A.M. Hussein; P. Benedetto; S.M. Waldman; L.G. Feun; N. Savaraj; S.P. Richman; B. Ardalan; P. Desai

Phase II trial of mitoxantrone in head and neck carcinoma
American Journal of Clinical Oncology: Cancer Clinical Trials. 1991;14(4):298-304.

1
94.
1991

L.G. Feun; N. Savaraj; Y.-Y. Lee; H. Landy; J. Martinez-Prieto; C. Charnsangavej; J.D. Post; K.F. Lee; S. Wallace; B. Bowen; et al.

A pilot clinical and pharmacokinetic study of intracarotid cisplatin and bleomycin
Selective Cancer Therapeutics. 1991;7(1):29-36.

7
95.
1991

B. Ardalan; K.S. Sridhar; P. Benedetto; S. Richman; S. Waldman; L. Morrell; L. Feun; N. Savaraj; M. Fodor; A. Livingstone

A phase I, II study of high-dose 5-fluorouracil and high-dose leucovorin with low-dose phosphonacetyl-L-aspartic acid in patients with advanced malignancies
Cancer. 1991;68(6):1242-1246.

10
96.
1991

Bach Ardalan; Lucy Chua; Er-Ming Tian; Rajender Reddy; Kasi Sridhar; Pasquale Benedetto; Stephen Richman; Adrian Legaspi; Stuart Waldman; Louise Morrell; et al.

A phase II study of weekly 24-hour infusion with high-dose fluorouracil with leucovorin in colorectal carcinoma
Journal of Clinical Oncology. 1991;9(4):625-630.

194
97.
1991

L.G. Feun; J. Albores-Saavedra; N. Savaraj

Osteogenic sarcoma arising adjacent to a long-standing ameloblastoma: A case report
Oral Surgery Oral Medicine and Oral Pathology. 1991;71(1):77-79.

5
98.
1991

L.G. Feun; R. Gonzalez; N. Savaraj; J. Hanlon; M. Collier; W.A. Robinson; N.J. Clendeninn

Phase II trial of piritrexim in metastatic melanoma using intermittent, low-dose administration
Journal of Clinical Oncology. 1991;9(3):464-467.

17
99.
1991

Lynn G. Feun; Niramol Savaraj; Pasquale Benedetto; James Hanlon; Kasi S. Sridhar; Mary Collier; Stephen Richman; Sam H. Liao; Neil J. Clendeninn

Phase I trial of piritrexim capsules using prolonged, low-dose oral administration for the treatment of advanced malignancies
Journal of the National Cancer Institute. 1991;83(1):51-55.

10
100.
1990

L.G. Feun; M. Maor; D.J. Stewart; M.E. Leavens; N. Savaraj; G.P. Bodey

Pilot study of PCNU and cranial radiation therapy in the treatment of patients with malignant gliomas
Oncology. 1990;47(5):389-392.

0
101.
1990

L.G. Feun; N. Savaraj; H. Landy; H. Levin; T. Lampidis

Phase II study of homoharringtonine in patients with recurrent primary malignant central nervous system tumors
Journal of Neuro-Oncology. 1990;9(2):159-163.

10
102.
1990

L.G. Feun; Y.Y. Lee; C. Plager; N. Papadopoulos; N. Savaraj; C. Charnsangavej; R.S. Benjamin; S. Wallace

Intracarotid cisplatin-based chemotherapy in patients with malignant melanoma and central nervous system (CNS) metastases
American Journal of Clinical Oncology: Cancer Clinical Trials. 1990;13(5):448-451.

4
103.
1990

A.M. Hussein; L.G. Feun; N. Savaraj; D. East; D.T. Hussein

Carcinoid tumor presenting as central nervous system symptoms. Case report and review of th literature
American Journal of Clinical Oncology: Cancer Clinical Trials. 1990;13(3):251-255.

6
104.
1990

K.S. Sridhar; T.S. Anantha Samy; R.P. Agarwal; R.C. Duncan; P. Benedetto; A.G. Krishan; C.L. Vogel; L.G. Feun; N.M. Savaraj; S.P. Richman; et al.

A phase I study of 4'-0-tetrahydropyranyladriamycin. Clinical pharmacology and pharmacokinetics
Cancer. 1990;66(10):2082-2091.

1
105.
1990

L.G. Feun; N. Savaraj

Detection of occult bone metastasis by MRI scan.
Journal of the Florida Medical Association. 1990;77(10):881-883.

7
106.
1989

T.J. Lampidis; C. Castello; A. Del Giglio; B.C. Pressman; P. Viallet; K.W. Trevorrow; G.K. Valet; H. Tapiero; N. Savaraj

Relevance of the chemical charge of rhodamine dyes to multiple drug resistance
Biochemical Pharmacology. 1989;38(23):4267-4271.

31
107.
1989

A.M. Hussein; N. Savaraj; L.G. Feun; P. Ganjei; E. Donnelly

Carcinomatous meningitis from transitional cell carcinoma of the bladder: Case report
Journal of Neuro-Oncology. 1989;7(3):255-260.

11
108.
1989

A.N. Serafini; J. Kotler; L. Feun; M. Dewanjee; D. Robinson; D. Salk; G. Sfakianakis; P. Abrams; N. Savaraj; D. Goodwin; et al.

Technetium-99m labeled monoclonal antibodies in the detection of metastatic melanoma
Clinical Nuclear Medicine. 1989;14(8):580-587.

3
109.
1989

N. Savaraj; J. Liang; K. Lu; L.G. Feun; T.C. Hsu

Genotoxicity of [¹H]benz [de] isoquinoline-1, 3[²H]dione, 5 amino-2-, [2-(dimethylamino) ethyl] (BIDA) in human lymphocytes
Cancer Investigation. 1989;7(2):117-121.

3
110.
1988

L.G. Feun; N. Savaraj; S.S. Legha; E.G. Silva; R.S. Benjamin; M.A. Burgess

Chemotherapy for metastatic Merkel cell carcinoma: Review of the M.D. Anderson Hospital's experience
Cancer. 1988;62(4):683-685.

70
111.
1988

K. Lu; N. Savaraj; L.G. Feun; G. Zhengang; T. Umsawasdi; T.L. Loo

Pharmacokinetics of homoharringtonine in dogs
Cancer Chemotherapy and Pharmacology. 1988;21(2):139-142.

6
112.
1988

C.D.K. Chong; C.J. Logothetis; N. Savaraj; H.A. Fritsche; A.M. Gietner; M.L. Samuels

The correlation of vinblastine pharmacokinetics to toxicity in testicular cancer patients
Journal of Clinical Pharmacology. 1988;28(8):714-718.

7
113.
1987

Charles L. Vogel; Elizabeth Gorowski; Enrique Davila; Mario Eisenberger; James Kosinski; Ram P. Agarwal; Niramol Savaraj

Phase I clinical trial and pharmacokinetics of weekly ICRF-187 (NSC 169780) infusion in patients with solid tumors
Investigational New Drugs. 1987;5(2):187-198.

18
114.
1987

Lynn G. Feun; YaYen Lee; Wai-Kwan Alfred Yung; Niramol Savaraj; Sidney Wallace

Intracarotid VP-16 in malignant brain tumors
Journal of Neuro-Oncology. 1987;4(4):397-401.

11
115.
1987

N. Savaraj; K. Lu; L.G. Feun; M.A. Burgess; T.L. Loo

Comparison of CNS penetration, tissue distribution, and pharmacology of VP 16-213 by intracarotid and intravenous administration in dogs
Cancer Investigation. 1987;5(1):11-16.

3
116.
1987

Niramol Savaraj; Lynn G. Feun; Katherine Lu; Maam Leavens; Richard Moser; William S. Fields; Ti Li Loo

Central nervous system (CNS) penetration of homoharringtonine (HHT)
Journal of Neuro-Oncology. 1987;5(1):77-81.

5
117.
1987

J. Khorsand; R.L. Katz; N. Savaraj

Malignant carcinoid of the pancreas: a cytologic, ultrastructural, and immunocytochemical study of a case diagnosed by fine-needle aspiration of a supraclavicular node metastasis.
Diagnostic cytopathology. 1987;3(3):222-227.

10
118.
1987

K.C. Wright; L.C. Stephens; S. Wallace; N. Savaraj; L.G. Feun

Experimental combination chemotherapy: Intracarotid versus intravenous administration of aziridinylbenzoquinone, BCNU, and cisplatin in dogs
Chemotherapy. 1987;33(6):437-444.

0
119.
1986

L.G. Feun; Y.Y. Lee; W.K.A. Yung; C. Charnsangavej; N. Savaraj; R.A. Tang; S. Wallace

Phase II trial of intracarotid BCNU and cisplatin in primary malignant brain tumors
Cancer Drug Delivery. 1986;3(2):147-156.

5
120.
1986

Katherine Lu; Niramol Savaraj; John Kavanagh; Lynn G. Feun; Michael Burgess; Gerald P. Bodey; Ti Li Loo

Clinical pharmacology of 4-demethoxydaunorubicin (DMDR)
Cancer Chemotherapy and Pharmacology. 1986;17(2):143-148.

9
121.
1986

Niramol Savaraj; Lynn G. Feun; Katherine Lu; Sidney Wallace; William S. Fields; Ti Li Loo

Clinical pharmacology of intracarotid etoposide
Cancer Chemotherapy and Pharmacology. 1986;16(3):292-294.

0
122.
1986

Katherine Lu; Niramol Savaraj; Boh-Seng Yap; Lynn G. Feun; Theera Umsawasdi; Ti Li Loo

Clinical pharmacolinetics of 9, 10-anthracenedicarboxaldehyde-bis [(4,5-dihydro-1 H-imidazol-2-yl)hydrazone]dihydrochloride
Cancer Chemotherapy And Pharmacology. 1986;16(2):156-159.

1
123.
1986

R. Pasterz; N. Savaraj; M. Burgess

Prognostic factors in metastatic carcinoma of unknown primary
Journal of Clinical Oncology. 1986;4(11):1652-1657.

32
124.
1986

N. Savaraj; K. Lu; I. Dimery; L.G. Feun; M. Burgess; M. Keating; T.L. Loo

Clinical pharmacology of homoharringtonine
Cancer Treatment Reports. 1986;70(12):1403-1407.

12
125.
1985

L.G. Feun; W.K.A. Yung; D.J. Stewart; N. Savaraj; G.P. Bodey

Phase II trial of mitoqauzone in malignant primary brain tumors
Cancer Treatment Reports. 1985;69(3):329-330.

0
126.
1985

N. Savaraj; K. Lu; L.G. Feun

Interaction of [³H]homoharringtonine (HHT) with the calcium antagonist receptor in the rat
Proceedings of the American Association for Cancer Research. 1985;VOL. 26:No. 1417.

1
127.
1985

D.C. Wang; N. Savaraj; K. Lu

Comparison of CSF penetration of VP-16 by intracarotid (IC) intravenous (IV) and intraventricular route (IT) in dogs
Proceedings of the American Association for Cancer Research. 1985;VOL. 26:No. 1416.

0
128.
1985

K. Lu; N. Savaraj; L.G. Feun

Pharmacokinetics of caracemide (CAR, NSC-253272) in dogs
Proceedings of the American Association for Cancer Research. 1985;VOL. 26:No. 1418.

0
129.
1985

L.D. Feldman; L.G. Feun; R.S. Benjamin; B.S. Yap; C. Plager; N. Papadopoulos; N. Savaraj; M.A. Burgess; G.P. Bodey

A phase II trial of PCNU in patients with malignant melanoma and central nervous system metastases
American Journal of Clinical Oncology: Cancer Clinical Trials. 1985;8(3):215-217.

1
130.
1985

L.G. Feun; Y.Y. Lee; S. Wallace; C. Charnsangavej; N. Savaraj; C.H. Carrasco; C. Gianturco; W.K. Yung

New drugs and new delivery techniques.
Progress in experimental tumor research. Fortschritte der experimentellen Tumorforschung. Progres de la recherche experimentale des tumeurs. 1985;29:131-139.

0
131.
1985

J.J. Kavanagh; K.Y. Yeung; N. Savaraj; I.H. Krakoff

Phase I clinical evaluation of oral and intravenous 4-demethoxydaunorubicin
European Journal of Cancer and Clinical Oncology. 1985;21(10):1187-1189.

1
132.
1985

Katherine Lu; Nimarol Savaraj; Robert A. Newman

High-performance liquid chromatographic separation and quantitation of benzisoquinolinedione (Nafidimide) from biological fluids
Journal of Chromatography B: Biomedical Sciences and Applications. 1985;345(C):408-412.

0
133.
1985

Eugenie AMT Obbens; Lynn G. Feun; Milam E. Leavens; Niramol Savaraj; David J. Stewart; Jordan U. Gutterman

Phase I clinical trial of intralesional or intraventricular leukocyte interferon for intracranial malignancies
Journal of Neuro-Oncology. 1985;3(1):61-67.

8
134.
1985

L.G. Feun; N. Savaraj; K. Lu

Effects of activated charcoal on the pharmacokinetics and toxicity of cisplatin (CDDP)
Proceedings of the American Association for Cancer Research. 1985;VOL. 26:No. 1039.

0
135.
1984

L.G. Feun; N. Savaraj; A.T. Ozarda

Cisplatin in medulloblastoma with extracranial metastasis: A case report
Cancer Treatment Reports. 1984;68(10):1307-1309.

1
136.
1984

L.G. Feun; S. Wallace; D.J. Stewart; V.P. Chuang; W.K. Yung; M.E. Leavens; M.A. Burgess; N. Savaraj; R.S. Benjamin; S.E. Young

Intracarotid infusion of cis-diamminedichloroplatinum in the treatment of recurrent malignant brain tumors
Cancer. 1984;54(5):794-799.

37
137.
1984

L.G. Feun; N. Savaraj; G.P. Bodey; K. Lu; B.S. Yap; J.A. Ajani; M.A. Burgess; R.S. Benjamin; E. McKelvey; I. Krakoff

Phase I study of tricyclic nucleoside phosphate using a five-day continuous infusion schedule
Cancer Research. 1984;44(8):3608-3612.

41
138.
1984

K. Lu; N. Savaraj; T.L. Loo

Pharmacological disposition of 1,4-dihydroxy-5-8-bis[[2[(2-hydroxyethal)amino] ethyl]amino]-9,10-anthracenedione dihydrochloride in the dog
Cancer Chemotherapy and Pharmacology. 1984;13(1):63-66.

8
139.
1984

David J. Stewart; Guo Zhengang; Katherine Lu; Niramol Savaraj; Lynn G. Feun; Mario Luna; Robert S. Benjamin; Michael J. Keating; Ti Li Loo

Human tissue distribution of 4′-(9-acridinylamino)-methanesulfon-m-anisidide (NSC 141549, AMSA)
Cancer Chemotherapy and Pharmacology. 1984;12(2):116-119.

2
140.
1984

L.G. Feun; S. Wallace; W.-K.A. Yung; Y.Y. Lee; M.E. Leavens; R. Moser; N. Savaraj; M.A. Burgess; C. Plager; R.S. Benjamin

Phase-I trial of intracarotid BCNU and cisplatin in patients with malignant intracerebral tumors
Cancer Drug Delivery. 1984;1(3):239-245.

5
141.
1984

Kenneth C. Wright; Chusilp Charnsangavej; Sidney Wallace; Vincent P. Chuang; Niramol Savaraj

Regional isolation-perfusion: An experimental percutaneous approach tested and compared with arterial occlusion-infusion
CardioVascular and Interventional Radiology. 1984;7(6):294-298.

0
142.
1983

Niramol Savaraj; Katherine Lu; Lynn G. Feun; Milam E. Leavens; David Stewart; Michael A. Burgess; Robert S. Benjamin; Ti Li Loo

Intracerebral penetration and tissue distribution of 2,5-diaziridinyl 3,6-bis(carboethoxyamino) 1,4-benzoquinone (AZQ, NSC-182986)
Journal of Neuro-Oncology. 1983;1(1):15-19.

1
143.
1983

Katherine Lu; Niramol Savaraj; Boh Seng Yap; Agop Y. Bedikian; Lynn Feun; Robert S. Benjamin; Ti Li Loo

Clinical pharmacology of 2,5′-diaziridinyl-3,6-biscarboethoxyamino-1,4-benzoquinone (AZQ)
European Journal of Cancer and Clinical Oncology. 1983;19(5):603-606.

0
144.
1983

Lynn G. Feun; David J. Stewart; Moshe Maor; Milam Leavens; Niramol Savaraj; M.Andrew Burgess; Wai-Kwan A. Yung; Robert S. Benjamin

A pilot study of cis-diamminedichloroplatinum and radiation therapy in patients with high grade astrocytomas
Journal of Neuro-Oncology. 1983;1(2):109-113.

15
145.
1983

Ti Li Loo; L. Jiushi; K. Lu; N. Savaraj

Clinical pharmacokinetics of 5-methyltetrahydrohomofolate
Cancer Research. 1983;43(2):921-924.

0
146.
1983

Lynn G. Feun; David J. Stewart; Milam E. Leavens; M.Andrew Burgess; Niramol Savaraj; Robert S. Benjamin; G.P. Bodey

A phase II trial of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea (PCNU, NSC 95466) in recurrent malignant brain tumors
Journal of Neuro-Oncology. 1983;1(1):45-48.

3
147.
1983

G. Zhengang; N. Savaraj; L.G. Feun

Tumor penetration of AMSA in man
Cancer Investigation. 1983;1(6):475-478.

1
148.
1983

Lynn G. Feun; Niramol Savaraj; Katherine Lu; Zhengang Guo; L.Gilbert Raulston; Robert S. Benjamin; William S. Fields; Ti Li Loo

The pharmacologic fate of 2,5-diaziridinyl-3,6-bis(carboethoxyamino) 1,4-benzoquinone (AZQ NSC-182986) by intracarotid or intravenous administration in beagles
Journal of Neuro-Oncology. 1983;1(3):219-224.

0
149.
1982

L.G. Feun; N. Savaraj; A.Y. Bedikian

Phase II study 2,5-diaziridinyl-3,6-bis-carboethoxyamino-1,4-benzoquinone (AZQ, NSC 182986) in recurrent malignant gliomas
Proceedings of the American Association for Cancer Research. 1982;Vol. 23:596.

0
150.
1982

Z.G. Guo; K. Lu; N. Savaraj

Pharmacology fate of 2,5-diaziridinyl-3,6-biscarboethoxyamino-1,4-benzoquinone (AZQ NSC-182986) by intracarotid (IC) or intravenous (IV) administration in beagles
Proceedings of the American Association for Cancer Research. 1982;Vol. 23:No. 861.

0
151.
1982

Niramol Savaraj; Katherine Lu; Manuel Valdivieso; Michael Burgess; Theera Umsawasdi; Robert S. Benjamin; Ti Li Loo

Clinical kinetics of 1,4-dihydroxy-5,8-bis [[2-[(2-hydroxyethyl)amino]ethyl] amino]9,10-anthracenedione
Clinical Pharmacology and Therapeutics. 1982;31(3):312-316.

2
152.
1982

T.L. Loo; B.S. Yap; K. Lu; N. Savaraj

Effects of cimetidine on the clinical pharmacokinetics of 2,5-diaziridinyl-3,6-bis(carboethoxyamino)-1,4-benzoquinone (AZQ, NSC-182986)
Clinical Pharmacology and Therapeutics. 1982;31(2):245.

0
153.
1982

N. Savaraj; D. Stewart; K. Lu

Tissue distribution of AMSA in patients
Proceedings of the American Society of Clinical Oncology. 1982;Vol. 1:C-69.

0
154.
1982

K. Lu; N. Savaraj; M.T. Huang

High performance liquid chromatography (HPLC) of the new antineoplastic 9,10-anthracenedicarboxaldehyde bis[4,5-dihydro-1 H-imidazole-2-yl) hydrazone]dihydrochloride (Cl 216,942; Bisantrene)
Journal of Liquid Chromatography. 1982;5(7):1323-1328.

0
155.
1982

Z. Guo; N. Savaraj; R. Smith

Clinical pharmacology of 1-(2-cloroethyl)-3-(2,6-dioxo-1-piperidyl)-1-nitro-sourea (PCNU, NSC-95466)
Clinical Pharmacology and Therapeutics. 1982;31(2):232.

0
156.
1982

K.L. Yeung; N. Savaraj; Boh Seng Yap

Clinical pharmacology of 9,10-anthracenedicarboxaldehyde bis[(4,5-dihydro-1H-imidazole-2-yl)hydrazone] dihydrochloride (bisantrene, NSC-337766)
Proceedings of the American Association for Cancer Research. 1982;Vol. 23:487.

0
157.
1982

Niramol Savaraj; Katherine Lu; Valdivieso Manuel; Ti Li Loo

Pharmacology of mitoxantrone in cancer patients
Cancer Chemotherapy and Pharmacology. 1982;8(1):113-117.

14
158.
1982

K. Lu; N. Savaraj; L. Feun

Clinical pharmacology and intracerebral tumor penetration of 4'-demethyl epipodophyllotoxin 9-(4,6-O-ethylidene-β-D-glucopyranoside) (VP-16, NSC-141540)
Clinical Pharmacology and Therapeutics. 1982;31(2):245.

1
159.
1982

N. Savaraj; K. Lu; G.L. Raulston

Comparison of CNS penetration, tissue distribution, and pharmacology of 4'-demethyl epipodophyllotoxin 9-(4,6-O-ethylidene-β-D-glucopyranoside) (VP-16), NSC-141540) intracarotid (IC) vs. intravenous administration (IV) in dogs
Proceedings of the American Association for Cancer Research. 1982;Vol. 23:No. 791.

0
160.
1981

N. Savaraj; K. Lu; D. Stewart

Tissue distribution and intracerebral tumor penetration of 2,5-diaziridinyl-3,6-biscarboethoxyamino-1,4-benzoquinone (AZO, NSC 182986) in man
Proceedings of the American Association for Cancer Research. 1981;Vol. 22:C-74.

0
161.
1981

M. Valdivieso; A.Y. Bedikian; M.A. Burgess; N. Savaraj; W.B. Jeffers; G.P. Bodey

Phase I clinical study of dihydroxyanthracenedione administered on a 5-day iv schedule
Cancer Treatment Reports. 1981;65(9-10):841-844.

1
162.
1981

N. Savaraj; K. Lu; B.S. Yap

Pharmacologic study of vindesine by continuous intravenous infusion in cancer patients
Clinical Pharmacology and Therapeutics. 1981;29(2):280.

0
163.
1981

K. Lu; N. Savaraj; B.S. Yap

Clinical pharmacology of 2,5-diaziridinyl-3,6-bis-carboethoxyamino-1,4-benzoquinone, (AZQ, NSC 182986)
Proceedings of the American Association for Cancer Research. 1981;Vol. 22:714.

0
164.
1981

J.S. Liu; K. Lu; N. Savaraj

Clinical pharmacologic studies of 5-methyltetrahydrohomofolate (MTHHF, NSC 139490)
Proceedings of the American Association for Cancer Research. 1981;Vol. 22:715.

0
165.
1981

N. Savaraj; K. Lu; M. Valdivieso

Clinical pharmacokinetics of 1,4 dihydroxy-5-8 bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-9,10-anthracenedione dihydrochloride (DHAQ, NSC 279836)
Proceedings of the American Association for Cancer Research. 1981;Vol. 22:713.

0
166.
1981

K. Lu; N. Savaraj; M. Valdivieso

The binding of 1,4-dihydroxy-5,8-bis-ADAD2-BD(2-hydroxyethyl)aminoBDethylBDaminoBD9,10-anthracenedione dihydrochloride (DHAO,NSC279836) to human blood cells
Proceedings of the American Association for Cancer Research. 1981;Vol. 22:C-72.

0
167.
1981

E.C.-Y. Lian; N. Savaraj

Effects of platelet inhibitors on the platelet aggregation induced by plasma from patients with thrombotic thrombocytopenic purpura
Blood. 1981;58(2):354-359.

6
168.
1980

N. Savaraj; L.M. Allen; C. Sutton; M. Troner

Immunological modification of adriamycin cardiotoxicity
Research Communications in Chemical Pathology and Pharmacology. 1980;29(3):549-559.

1
169.
1980

N. Savaraj; M.B. Troner

Aminoglutethimide in the management of metastatic breast cancer
Medical and Pediatric Oncology. 1980;8(3):251-263.

0
170.
1978

M.B. Troner; N. Savaraj

Medical adrenalectomy with aminoglutethimide (AG) in metastatic breast cancer
Proceedings of the American Association for Cancer Research. 1978;Vol. 19:No. C-410.

0
171.
1978

N. Savaraj

The influence of vincristine (VCR) on the postinfusion clinical pharmacokinetics of methotrexate (MTX)
Proceedings of the American Association for Cancer Research. 1978;Vol. 19:No. 420.

0
172.
1977

M.B. Troner; N. Savaraj; L. Fishman

Medical adrenalectomy with aminoglutethimide (AG) in the treatment of metastatic breast cancer
Proceedings of the American Association for Cancer Research. 1977;Vol.18:No.C-97.

0

Niramol Savaraj SCHOOL OF MEDICINE, MEDICINE

Niramol Savaraj

172 Publications

Niramol Savaraj
SCHOOL OF MEDICINE, MEDICINE